These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21897161)

  • 1. Pediatric cardiopulmonary bypass and the inflammatory response: years of investigation, only incremental progress.
    Kern FH
    Pediatr Crit Care Med; 2011 Sep; 12(5):594-6. PubMed ID: 21897161
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibition alters the inflammatory and fibrinolytic response to cardiopulmonary bypass in children.
    Fleming GA; Billings FT; Klein TM; Bichell DP; Christian KG; Pretorius M
    Pediatr Crit Care Med; 2011 Sep; 12(5):532-8. PubMed ID: 20975611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of preoperative angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use on hemodynamic variables in pediatric patients undergoing cardiopulmonary bypass.
    Ajuba-Iwuji CC; Puttreddy S; Maxwell BG; Bembea M; Vricella L; Heitmiller E
    World J Pediatr Congenit Heart Surg; 2014 Oct; 5(4):515-21. PubMed ID: 25324247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimizing systemic inflammation during cardiopulmonary bypass in the pediatric population.
    Durandy Y
    Artif Organs; 2014 Jan; 38(1):11-8. PubMed ID: 24392866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial function, fibrinolysis, and angiotensin-converting enzyme inhibition.
    Vaughan DE
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-34-7. PubMed ID: 9422850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibition and smoking potentiate the kinin response to cardiopulmonary bypass.
    Pretorius M; McFarlane JA; Vaughan DE; Brown NJ; Murphey LJ
    Clin Pharmacol Ther; 2004 Oct; 76(4):379-87. PubMed ID: 15470338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden hyperkalemia during cardiopulmonary bypass with hypothermic cardiac arrest in an infant.
    Ivens D; Camu F
    J Cardiothorac Vasc Anesth; 1996 Feb; 10(2):258-60. PubMed ID: 8850410
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass.
    Khalil PN; Ismail M; Kalmar P; von Knobelsdorff G; Marx G
    Thromb Haemost; 2004 Sep; 92(3):568-74. PubMed ID: 15351853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of high dose aprotinin therapy on the systemic inflammatory response in a porcine model of cardiopulmonary bypass.
    Ali M; Becket J; Brannan J; Fleming J; Taylor KM
    Perfusion; 1996 May; 11(3):278-80. PubMed ID: 8817637
    [No Abstract]   [Full Text] [Related]  

  • 10. [Factors involved in the development of vasoplegia after cardiac surgery with extracorporeal circulation. A prospective observational study].
    Durán Bruce M; Gomar Sancho C; Holguera JC; Muliterno Español E
    Rev Esp Anestesiol Reanim; 2014 May; 61(5):246-53. PubMed ID: 24507583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
    Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
    Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemorrhage after bypass surgery.
    Spiess BD; McCarthy RJ; Tuman KJ; Ivankovich AD
    Chest; 1990 Jul; 98(1):255-6. PubMed ID: 2361408
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin converting enzyme inhibitors--do they have an anti-ischemic action?
    Rutherford JD
    Trans Am Clin Climatol Assoc; 1996; 107():57-66; discussion 66-7. PubMed ID: 8725560
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress.
    Gourlay T; Shedden L
    Perfusion; 2010 Nov; 25(6):427-9; author reply 429-30. PubMed ID: 21098552
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of the neutrophil elastase inhibitor sivelestat on perioperative inflammatory response after pediatric heart surgery with cardiopulmonary bypass: a prospective randomized study.
    Kohira S; Oka N; Inoue N; Itatani K; Hanayama N; Kitamura T; Fujii M; Takeda A; Oshima H; Tojo K; Yoshitake S; Miyaji K
    Artif Organs; 2013 Dec; 37(12):1027-33. PubMed ID: 23834653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inflammatory response to cardiopulmonary bypass: part 1--mechanisms of pathogenesis.
    Warren OJ; Smith AJ; Alexiou C; Rogers PL; Jawad N; Vincent C; Darzi AW; Athanasiou T
    J Cardiothorac Vasc Anesth; 2009 Apr; 23(2):223-31. PubMed ID: 18930659
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors and risk of acute kidney injury after cardiac surgery.
    Bouzas-Mosquera A; Alvarez-García N; Peteiro J
    Ann Thorac Surg; 2009 May; 87(5):1653; author reply 1653-4. PubMed ID: 19379947
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibition and fibrinolytic balance.
    Matsumoto T; Horie M
    Hypertens Res; 2011 Apr; 34(4):448-9. PubMed ID: 21326308
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic angiotensin converting inhibition does not influence renal hemodynamic and function during cardiac surgery.
    Licker M; Schweizer A; Höhn L; Morel DR
    Can J Anaesth; 1999 Jul; 46(7):626-34. PubMed ID: 10442956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of takotsubo cardiomyopathy occurring during cardiopulmonary bypass.
    Itoh H; Miyake Y; Hioki I; Tanaka S; Okabe M
    J Extra Corpor Technol; 2007 Jun; 39(2):109-11. PubMed ID: 17672194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.